Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
bispecific antibodies approved by fda | 1.58 | 0.4 | 862 | 4 | 37 |
bispecific | 1.45 | 0.7 | 1656 | 24 | 10 |
antibodies | 0.22 | 1 | 4268 | 7 | 10 |
approved | 1.09 | 0.4 | 320 | 41 | 8 |
by | 1.31 | 0.2 | 832 | 21 | 2 |
fda | 0.23 | 0.4 | 7811 | 60 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
bispecific antibodies approved by fda | 1.27 | 0.7 | 1543 | 95 |
bispecific antibody approved by fda | 1.31 | 0.7 | 6678 | 11 |
first bispecific antibody approved by fda | 1.97 | 1 | 7898 | 72 |
list of approved bispecific antibodies | 0.85 | 1 | 1823 | 93 |
bispecific antibody development programs fda | 0.88 | 0.1 | 7610 | 13 |
bispecific antibodies in clinical trials | 1.84 | 0.4 | 4412 | 48 |
fda bispecific antibody guidance | 2 | 0.1 | 8176 | 56 |
bispecific antibodies and their applications | 0.66 | 0.3 | 2009 | 50 |
fda guidance bispecific antibody development | 1.03 | 0.3 | 2841 | 9 |
bispecific antibodies in oncology | 0.06 | 0.8 | 395 | 20 |
what are bispecific antibodies | 0.52 | 0.7 | 7831 | 77 |
list of bispecific antibodies | 1.61 | 1 | 5094 | 44 |
bispecific antibody review 2022 | 1.47 | 0.3 | 6691 | 28 |
bispecific antibodies for cancer therapy | 0.48 | 0.6 | 7569 | 60 |
bispecific and trispecific antibodies | 0.24 | 0.7 | 4674 | 72 |
bispecific antibody format review | 1.91 | 0.3 | 508 | 52 |
bispecific antibody nature review | 1.16 | 0.4 | 9362 | 4 |